Discovery of a Novel Chemotype of Tyrosine Kinase Inhibitors by Fragment-Based Docking and Molecular Dynamics
about
Fragment-based docking: development of the CHARMMing Web user interface as a platform for computer-aided drug design.Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases.Structured water molecules in the binding site of bromodomains can be displaced by cosolvent.Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective.
P2860
Discovery of a Novel Chemotype of Tyrosine Kinase Inhibitors by Fragment-Based Docking and Molecular Dynamics
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Discovery of a Novel Chemotype ...... Docking and Molecular Dynamics
@ast
Discovery of a Novel Chemotype ...... Docking and Molecular Dynamics
@en
Discovery of a Novel Chemotype ...... Docking and Molecular Dynamics
@nl
type
label
Discovery of a Novel Chemotype ...... Docking and Molecular Dynamics
@ast
Discovery of a Novel Chemotype ...... Docking and Molecular Dynamics
@en
Discovery of a Novel Chemotype ...... Docking and Molecular Dynamics
@nl
prefLabel
Discovery of a Novel Chemotype ...... Docking and Molecular Dynamics
@ast
Discovery of a Novel Chemotype ...... Docking and Molecular Dynamics
@en
Discovery of a Novel Chemotype ...... Docking and Molecular Dynamics
@nl
P2093
P2860
P921
P356
P1476
Discovery of a Novel Chemotype ...... Docking and Molecular Dynamics
@en
P2093
Cristina Nevado
Karine Lafleur
P2860
P356
10.1021/ML3001984
P577
2012-10-11T00:00:00Z